What are Amphastar Pharmaceuticals's profit margins?

Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.

Where do Amphastar Pharmaceuticals's ratios come from?

Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Amphastar Pharmaceuticals AMPH Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	47.3%-2.1pp	49.5%+0.1pp	49.4%-0.5pp	49.9%-0.6pp	50.5%-0.6pp
Operating margin	16.2%-3.3pp	19.5%-1.2pp	20.7%-4.4pp	25.1%-1.5pp	26.6%-1.4pp
Net margin	11%-2.6pp	13.6%-1.8pp	15.4%-3.2pp	18.6%-0.7pp	19.4%-2.4pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Liquidity
Current ratio	3.9×-0.2×	4×+0.9×	3.1×-0.2×	3.3×+0.3×	3×-0.1×
Leverage
Net debt / EBITDA	3×+0.5×	2.5×+0.3×	2.1×+0.2×	2×+0.1×	1.9×0.0×
Valuation
Market capitalization	$926.83M-19.9%	$1.23B-0.7%	$1.24B+6.9%	$1.16B-16.1%	$1.38B-22.6%
Price / earnings	11.7×+3.5×	12.5×+1.4×	11.1×+2.5×	8.6×-1.2×	9.8×-1.4×
Price / sales	1.3×-0.3×	1.7×0.0×	1.7×+0.1×	1.6×-0.3×	1.9×-0.5×
EV / EBITDA	8.3×+1.7×	8.7×+0.5×	8.2×+1.3×	6.9×-0.6×	7.5×-1.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Amphastar Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Amphastar Pharmaceuticals's profit margins?: Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.
Where do Amphastar Pharmaceuticals's ratios come from?: Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.